Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development and Validation of a Prognostic Model for Idiopathic Membranous Nephropathy Treated With Rituximab

NCT05667909 is registered in ClinicalTrials.gov with Qianfoshan Hospital as lead sponsor.

NCT NCT05667909
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05667909 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development and Validation of a Prognostic Model for Idiopathic Membranous Nephropathy Treated With Rituximab
Lead sponsor
Qianfoshan Hospital
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2023
Completion date
December 31, 2023
Enrollment
50 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic membranous nephropathy